NOONAN SYNDROME 9
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.
|
25795793 |
2015 |
NOONAN SYNDROME 9
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome.
|
26173643 |
2015 |
NOONAN SYNDROME 9
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome.
|
26173643 |
2015 |
NOONAN SYNDROME 9
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.
|
25795793 |
2015 |
NOONAN SYNDROME 9
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.
|
25795793 |
2015 |
NOONAN SYNDROME 9
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
NOONAN SYNDROME 9
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
NOONAN SYNDROME 9
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Noonan Syndrome
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
We identified two novel genes, SOS2 and LZTR1, associated with Noonan syndrome, thereby expanding the molecular spectrum of RASopathies.
|
25795793 |
2015 |
Noonan Syndrome
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
Similar to NS-causing SOS1 mutations, the phenotype associated with SOS2 defects is characterized by normal development and growth, as well as marked ectodermal involvement.
|
26173643 |
2015 |
Noonan Syndrome
|
0.620 |
Biomarker
|
disease |
CLINGEN |
We identified two novel genes, SOS2 and LZTR1, associated with Noonan syndrome, thereby expanding the molecular spectrum of RASopathies.
|
25795793 |
2015 |
Noonan Syndrome
|
0.620 |
GermlineCausalMutation
|
disease |
ORPHANET |
We identified two novel genes, SOS2 and LZTR1, associated with Noonan syndrome, thereby expanding the molecular spectrum of RASopathies.
|
25795793 |
2015 |
Noonan Syndrome
|
0.620 |
Biomarker
|
disease |
CLINGEN |
Similar to NS-causing SOS1 mutations, the phenotype associated with SOS2 defects is characterized by normal development and growth, as well as marked ectodermal involvement.
|
26173643 |
2015 |
Noonan Syndrome
|
0.620 |
Biomarker
|
disease |
CLINGEN |
The RASopathies.
|
23875798 |
2013 |
Noonan Syndrome
|
0.620 |
Biomarker
|
disease |
CLINGEN |
Ras-guanine nucleotide exchange factor sos2 is dispensable for mouse growth and development.
|
10938118 |
2000 |
Noonan Syndrome
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Ras-guanine nucleotide exchange factor sos2 is dispensable for mouse growth and development.
|
10938118 |
2000 |
Hydrops Fetalis
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
LEOPARD Syndrome
|
0.300 |
Biomarker
|
disease |
CLINGEN |
|
|
|
Costello syndrome (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
|
|
|
Cardio-facio-cutaneous syndrome
|
0.300 |
Biomarker
|
disease |
CLINGEN |
|
|
|
Noonan syndrome-like disorder with loose anagen hair
|
0.300 |
Biomarker
|
disease |
CLINGEN |
|
|
|
Noonan-Like Syndrome With Loose Anagen Hair
|
0.300 |
Biomarker
|
disease |
CLINGEN |
|
|
|
Birth Weight
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors.
|
31043758 |
2019 |
Cardiovascular Diseases
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Vital capacity
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |